Enovis (ENOV) Change in Acquisitions & Divestments (2018)

Enovis' (ENOV) quarterly Change in Acquisitions & Divestments came in at $139.5 million in Q2 2018.

Enovis (ENOV) Change in Acquisitions & Divestments (2018) Analysis & Trends

Enovis (ENOV) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $139.5 million in Q2 2018.

On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $139.5 million in Q2 2018; TTM through Dec 2019 was $139.5 million, a 0.0% change from a year earlier, with the FY2018 full-year figure at $139.5 million, changed N/A from the prior year.
Change in Acquisitions & Divestments for Q2 2018 stood at $139.5 million.
Over the last five years, Change in Acquisitions & Divestments for ENOV reached as high as $139.5 million in Q2 2018 and fell as low as $139.5 million in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	Enovis	1.61 Bn	1.58 Bn	365.49 Mn

Download Data

Date	Value
Jun 29, 2018	139.50 Mn
Jun 29, 2018	139.50 Mn